Mainz Biomed N.V (MYNZ) Shares Outstanding (Weighted Average): 2020-2025
Historic Shares Outstanding (Weighted Average) for Mainz Biomed N.V (MYNZ) over the last 2 years, with Jun 2025 value amounting to $2.3 million.
- Mainz Biomed N.V's Shares Outstanding (Weighted Average) rose 338.33% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year increase of 338.33%. This contributed to the annual value of $639,664 for FY2024, which is 52.78% up from last year.
- Latest data reveals that Mainz Biomed N.V reported Shares Outstanding (Weighted Average) of $2.3 million as of Q2 2025, which was up 262.59% from $639,664 recorded in Q4 2024.
- In the past 5 years, Mainz Biomed N.V's Shares Outstanding (Weighted Average) ranged from a high of $2.3 million in Q2 2025 and a low of $292,750 during Q4 2021.
- Its 3-year average for Shares Outstanding (Weighted Average) is $722,609, with a median of $418,686 in 2023.
- Data for Mainz Biomed N.V's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 338.33% (in 2025) over the last 5 years.
- Quarterly analysis of 5 years shows Mainz Biomed N.V's Shares Outstanding (Weighted Average) stood at $292,750 in 2021, then grew by 23.68% to $362,074 in 2022, then rose by 15.64% to $418,686 in 2023, then spiked by 52.78% to $639,664 in 2024, then surged by 338.33% to $2.3 million in 2025.
- Its last three reported values are $2.3 million in Q2 2025, $639,664 for Q4 2024, and $529,137 during Q2 2024.